Published in

Cell Press, Neuron, 2(77), p. 212-213, 2013

DOI: 10.1016/j.neuron.2013.01.009

Links

Tools

Export citation

Search in Google Scholar

Fragile X Syndrome Therapeutics: Translation, Meet Translational Medicine

Journal article published in 2013 by Jonathan Lipton, Mustafa Sahin ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Fragile X syndrome, a common cause of intellectual disability and autism, is thought to occur due to abnormal regulation of neuronal protein synthesis. A study by Osterweil et al. (2013), in this issue, demonstrates that the HMG-CoA reductase inhibitor lovastatin can normalize protein synthesis and also reduce audiogenic seizures in Fmr1 knockout mice.